Hep Email Update How New York City Plans to End Viral Hepatitis by 2030 Reaching these three goals will help New York City eliminate viral hepatitis as a public health threat. Surprise Tournament of Roses Parade After Liver Cancer Scare There are not enough words to describe Karen Hoyt’s joy after being told she would be riding in the Tournament of Roses Parade with her organ donor. Alert! Obamacare Open Enrollment Ends January 15 Plus: The White House moves to ensure that future ACA health plans cost less, protect those with chronic illness and don’t discriminate. Advertisement Virginia Medicaid Eases Access to Hepatitis C Treatment Providers will no longer have to file burdensome preauthorization forms to get Virginia Medicaid’s approval for hepatitis C meds. New Venture Offers Free and Discounted Meds for Chronic Hepatitis B The Hepatitis B Foundation and Rx Outreach will supply two frontline medications: tenofovir and entecavir. Here’s how to enroll. The Hep Magazine Archives To read past issues of Hep, click the link! Advertisement Science News FDA OKs Second COVID Antiviral Pill for Limited Use FDA Authorizes First Antiviral Pill for COVID-19 Alaska Natives Successfully Treated With Antiviral Therapy for Hepatitis C Weight Loss Surgery Linked to Lower Risk for Liver and Heart Complications Newsfeed Alert! Obamacare Open Enrollment Ends January 15 How New York City Plans to End Viral Hepatitis by 2030 9 Ways to Address Hepatitis B Stigma and Discrimination [VIDEO] You Know of Hepatitis A, B and C. Here’s HUC: Hepatitis of Unknown Cause Science News FDA OKs Second COVID Antiviral Pill for Limited Use FDA Authorizes First Antiviral Pill for COVID-19 Alaska Natives Successfully Treated With Antiviral Therapy for Hepatitis C Weight Loss Surgery Linked to Lower Risk for Liver and Heart Complications Newsfeed Alert! Obamacare Open Enrollment Ends January 15 How New York City Plans to End Viral Hepatitis by 2030 9 Ways to Address Hepatitis B Stigma and Discrimination [VIDEO] You Know of Hepatitis A, B and C. Here’s HUC: Hepatitis of Unknown Cause

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: